| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Cell Physiology, Vol 260, Issue 5 C1052-C1059, Copyright © 1991 by American Physiological Society
ARTICLES |
E. G. Langeler and V. W. van Hinsbergh
Gaubius Institute TNO, Leiden, The Netherlands.
The barrier function of human artery endothelial cells was improved by addition of agents that increase the cellular adenosine 3',5'-cyclic monophosphate (cAMP) concentration. Together with a decrease in the passage rate of peroxidase, an increase in the transendothelial electrical resistance was observed. A direct correlation was found between the relative increases in cellular cAMP concentration and the relative decrease in peroxidase passage after incubation of the cells with forskolin (0.25 and 2.5 microM), the beta-adrenergic agonist isoproterenol (10 microM), and the stable prostacyclin analogue iloprost (10 microM). Norepinephrine (10 microM) reduced the peroxidase passage to a much larger extent (40% reduction) than might be expected on the basis of a small increase of cAMP concentration. This small increase in cAMP (44%) was the result of interactions of norepinephrine with beta-adrenergic receptors, which increase cAMP, and alpha-adrenergic receptors, which decrease cAMP. The relatively strong reduction in permeability (also found in the presence of the alpha-adrenergic antagonist phentolamine) suggests that an additional cAMP-independent mechanism underlaid the barrier-improving effect of norepinephrine. A marked elevation of cAMP by forskolin was accompanied by a disappearance of F-actin and myosin from stress fibers. They were found diffusely spread over the cell, and F-actin in the cell periphery became prominently visible.
This article has been cited by other articles:
|
|
 |
|
  V. H. Huxley, J. J. Wang, and I. H. Sarelius Adaptation of coronary microvascular exchange in arterioles and venules to exercise training and a role for sex in determining permeability responses Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1196 - H1205. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Bodmer, A. English, M. Brady, K. Blackwell, K. Haxhinasto, S. Fotedar, K. Borgman, E.-W. Bai, and A. B. Moy Modeling error and stability of endothelial cytoskeletal membrane parameters based on modeling transendothelial impedance as resistor and capacitor in series Am J Physiol Cell Physiol, September 1, 2005; 289(3): C735 - C747. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Waschke, F. E. Curry, R. H. Adamson, and D. Drenckhahn Regulation of actin dynamics is critical for endothelial barrier functions Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1296 - H1305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Waschke, D. Drenckhahn, R. H. Adamson, H. Barth, and F. E. Curry cAMP protects endothelial barrier functions by preventing Rac-1 inhibition Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2427 - H2433. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Bindewald, D. Gunduz, F. Hartel, S. C. Peters, C. Rodewald, S. Nau, M. Schafer, J. Neumann, H. M. Piper, and T. Noll Opposite effect of cAMP signaling in endothelial barriers of different origin Am J Physiol Cell Physiol, November 1, 2004; 287(5): C1246 - C1255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. P. v. N. Amerongen, M. A. Vermeer, and V. W. M. van Hinsbergh Role of RhoA and Rho Kinase in Lysophosphatidic Acid-Induced Endothelial Barrier Dysfunction Arterioscler. Thromb. Vasc. Biol., December 1, 2000; 20 (12): e127 - e133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Essler, J. M. Staddon, P. C. Weber, and M. Aepfelbacher Cyclic AMP Blocks Bacterial Lipopolysaccharide-Induced Myosin Light Chain Phosphorylation in Endothelial Cells Through Inhibition of Rho/Rho Kinase Signaling J. Immunol., June 15, 2000; 164(12): 6543 - 6549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. M. Vischer, H. Barth, and C. B. Wollheim Regulated von Willebrand Factor Secretion Is Associated With Agonist-Specific Patterns of Cytoskeletal Remodeling in Cultured Endothelial Cells Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 883 - 891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Andriopoulou, P. Navarro, A. Zanetti, M. G. Lampugnani, and E. Dejana Histamine Induces Tyrosine Phosphorylation of Endothelial Cell-to-Cell Adherens Junctions Arterioscler. Thromb. Vasc. Biol., October 1, 1999; 19(10): 2286 - 2297. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C. Michel and F. E. Curry Microvascular Permeability Physiol Rev, July 1, 1999; 79(3): 703 - 761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. Adamson, B. Liu, G. N. Fry, L. L. Rubin, and F. E. Curry Microvascular permeability and number of tight junctions are modulated by cAMP Am J Physiol Heart Circ Physiol, June 1, 1998; 274(6): H1885 - H1894. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. F. Richard, T. E. Dahms, and R. O. Webster Adenosine prevents permeability increase in oxidant-injured endothelial monolayers Am J Physiol Heart Circ Physiol, January 1, 1998; 274(1): H35 - H42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-H. Chiang, K. Hsu, H.-C. Yan, H.-J. Harn, and D.-M. Chang PGE1, dexamethasone, U-74389G, or Bt2-cAMP as an additive to promote protection by UW solution in I/R injury J Appl Physiol, August 1, 1997; 83(2): 583 - 590. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Griffin Role for anions in pulmonary endothelial permeability J Appl Physiol, August 1, 1997; 83(2): 615 - 622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. W.M. van Hinsbergh Endothelial Permeability for Macromolecules: Mechanistic Aspects of Pathophysiological Modulation Arterioscler. Thromb. Vasc. Biol., June 1, 1997; 17(6): 1018 - 1023. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
